Tag: osteoporosis drugs market size

  • Osteoporosis Drugs Market Overview 2024: Size, Growth Drivers, and Major Segments

    Osteoporosis Drugs Market Overview 2024: Size, Growth Drivers, and Major Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Osteoporosis Drugs Market for the Period 2024 to 2033?

    In recent times, the osteoporosis drugs market has seen consistent expansion. It is projected to rise from a worth of $12 billion in 2023 to $12.48 billion in 2024, boasting a compound annual growth rate (CAGR) of 4.0%. This growth during the historical period is due to factors like the aging population, heightened diagnosis and awareness, lifestyle variables, government efforts, and health policy implementations.

    In the coming years, the market size of osteoporosis drugs is predicted to experience consistent growth, ultimately reaching $14.2 billion in 2028 at a compound annual growth rate (CAGR) of 3.3%. This growth during the predicted period can be credited to enduring trends in the aging population, advancements in therapy choices, increased attention towards the bone health in men, initiatives towards patient information and self-sufficiency, worldwide health policies, and insurance provisions. The anticipated period will also witness trends like the application of personalized medicine, research into combined therapies, efforts towards fracture prevention, investments in the research and development of innovative drug targets, as well as partnerships for drug development.

    Claim Your Free Sample of the Global Osteoporosis Drugs Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp

    What Factors Are Responsible for the Growth of the osteoporosis drugs Market?

    The anticipated spike in incidences of osteoporosis is poised to stimulate the osteoporosis drug market’s expansion. Osteoporosis manifests as a decline in the bone mineral density and mass bone, or changes in bone quality. Individuals whose diet lacks adequate calcium stand a higher likelihood of contracting osteoporosis. Drugs for osteoporosis bolster bone mineral density while curtailing the occurrence of fractures. Case in point, statistics by Amgen a biotechnology enterprise based in the U.S, indicate that approximately 1.5 million fracture cases in the U.S each year are attributable to osteoporosis, spurring an expenditure of $19 billion in relevant costs. Furthermore, the figure for fractures resulting from osteoporosis is projected to swell by 68% from 1.9 million in 2018 to 3.2 million in 2040. As such, this burgeoning occurrence of osteoporosis is a key driver for growth in the osteoporosis drug market.

    Which Segments Are Important for Insight into the Osteoporosis Drugs Market?

    1) By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors

    2) By Administration: Oral, Injectable

    3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales

    4) By Application: Primary Osteoporosis, Secondary Osteoporosis

    What Are the Significant Trends Reshaping the Osteoporosis Drugs Sector?

    Order Now for Fast Delivery of Your Osteoporosis Drugs Market Report!

    https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

    Which Regions Are Essential for the Growth of the Osteoporosis Drugs Market?

    North America was the largest region in the osteoporosis market in 2023. The regions covered in the osteoporosis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Osteoporosis Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the osteoporosis drugs market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Osteoporosis Drugs Market Include

    1. Osteoporosis Drugs Market Executive Summary

    2. Osteoporosis Drugs Market Segments

    3. Osteoporosis Drugs Market Size And Template Market Growth Rate

    4. Key Osteoporosis Drugs Market Trends

    5. Major Osteoporosis Drugs Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Osteoporosis Drugs Market

    26. Top Osteoporosis Drugs Companies

    27. Osteoporosis Drugs Market Opportunities And Strategies

    28. Osteoporosis Drugs Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Cardiovascular Surgery Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

    Cardiovascular Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

    Spinal Surgery Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/spinal-surgery-devices-and-equipment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Osteoporosis Drugs Market Report 2024: Market Size, Drivers, And Trends

    Osteoporosis Drugs Market Report 2024: Market Size, Drivers, And Trends

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    The osteoporosis drugs market has witnessed consistent growth in recent years, driven by various factors. This blog explores the market’s current status, future projections, key drivers, and emerging trends.

    Current Market Size and Growth Rate

    • Market Size and Growth:
      • The osteoporosis drugs market is valued at $12 billion in 2023 and is expected to reach $12.48 billion in 2024, with a CAGR of 4.0%.

    Future Market Growth Drivers

    • Continued Aging Population Trends:
      • As the population ages, the prevalence of osteoporosis is expected to increase, driving market growth.
    • Advancements in Treatment Options:
      • Ongoing research and development efforts are leading to the introduction of new and improved osteoporosis drugs.
    • Increased Focus on Men’s Bone Health:
      • Traditionally seen as a women’s health issue, there is a growing recognition of osteoporosis in men, leading to expanded treatment options.
    • Patient Education and Empowerment:
      • Increased awareness and education about osteoporosis empower patients to seek early diagnosis and treatment.
    • Global Health Policies and Insurance Coverage:
      • Supportive health policies and insurance coverage encourage individuals to seek treatment for osteoporosis.

    View More On The Osteoporosis Drugs Market Report 2024 – https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

    Major Trends in the Forecast Period

    • Personalized Medicine Approaches:
      • Tailoring treatment plans to individual patients’ needs improves efficacy and reduces side effects.
    • Exploration of Combination Therapies:
      • Combining different drugs or treatment modalities may enhance outcomes for osteoporosis patients.
    • Focus on Fracture Prevention Strategies:
      • Emphasizing preventive measures can reduce the incidence of osteoporotic fractures.
    • R&D Investment in Novel Drug Targets:
      • Research efforts are focused on identifying new drug targets and mechanisms of action for osteoporosis treatment.
    • Collaborations for Drug Development:
      • Partnerships between pharmaceutical companies and research institutions accelerate drug discovery and development.

    Rising Prevalence Of Osteoporosis Fuels Market Growth

    • Surge in Osteoporosis Prevalence:
      • Osteoporosis, characterized by decreased bone density, is becoming increasingly common, particularly among aging populations.
    • Impact of Osteoporotic Fractures:
      • Osteoporotic fractures contribute to significant healthcare costs and morbidity, underscoring the need for effective treatments.

    Key Players in the Osteoporosis Drugs Market

    • Major Companies:
      • Pfizer Inc.
      • F. Hoffmann La Roche Ltd.
      • Merck & Co Inc.
      • Novartis AG
      • Bristol Myers Squibb Company
      • GlaxoSmithKline PLC
      • Eli Lilly and Company
      • Amgen Inc.
      • Novo Nordisk A/S
      • Asahi Kasei Pharma Corporation
      • Viatris Inc.

    Strategic Partnerships Drive Innovations

    • Chugai Pharmaceutical Co. Ltd. and Towa Pharmaceutical Co. Ltd. Partnership:
      • Collaboration results in the launch of Edirol Tablet, providing a new treatment option for osteoporosis.

    Strategic Acquisitions Fuel Market Expansion

    • Nestlé Health Science’s Acquisition of Bountiful Company’s Core Brands:
      • Acquisition enhances Nestlé Health Science’s portfolio and global reach in the osteoporosis market.

    Market Segmentation

    • By Type:
      • Bisphosphonates
      • Selective Estrogen Receptor Modulators (SERMs)
      • RANK Ligand Inhibitors
    • By Administration:
      • Oral
      • Injectable
    • By Distribution Channel:
      • Retail Pharmacies
      • Hospital Pharmacies
      • Online Sales
    • By Application:
      • Primary Osteoporosis
      • Secondary Osteoporosis

    Regional Insights

    • North America:
      • Largest region in the osteoporosis market in 2023.

    In conclusion, the osteoporosis drugs market is poised for steady growth, driven by demographic trends, advancements in treatment options, and increasing awareness. Strategic collaborations, acquisitions, and innovative drug development efforts will shape the market’s future trajectory.

    Request A Sample Of The Global Osteoporosis Drugs Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9102&type=smp